[144] Dynatrace, Inc. SEC Filing

Rhea-AI Filing Summary

Dynatrace, Inc. (DT) notice files a Form 144 proposing to sell 90,000 common shares through The Charles Schwab Corporation with an approximate aggregate market value of $4,350,000. The filing reports 301,506,242 shares outstanding and lists the approximate sale date as 10/02/2025 on the NYSE.

The securities were reported as acquired from the issuer as RSU & PSU awards, with underlying grant dates between 11/18/2022 and 8/15/2024 and an acquisition/vesting/payment date of 06/05/2025. The filer reports no sales in the past three months in this notice.

Positive

• Brokered sale through a registered broker (The Charles Schwab Corporation) which supports orderly execution and compliance
• Acquisition via issuer awards (RSUs and PSUs) clearly documented with grant date range and vesting/payment date

Negative

• Large planned sale relative to typical insider trades: 90,000 shares valued at $4.35M could be perceived as insider liquidity
• No statement of reliance on a 10b5-1 trading plan or additional remarks in the filing to clarify timing or intent

Insights

Securities Compliance Analyst

TL;DR: Insider intends to sell vested equity awards: 90,000 DT shares valued at $4.35M, using a broker; no recent sales reported.

The filing is a routine Rule 144 notification indicating an intended sale of vested RSUs/PSUs. The use of a registered broker and the declaration of acquisition dates align with standard compliance for exempt resales. Absence of sales in the prior three months suggests this notice is for a first planned disposition following vesting. Investors should note the filing documents intent to sell but does not confirm execution or any trading plan date beyond the approximate sale date provided.

Corporate Governance Specialist

TL;DR: This is a procedural disclosure of award-derived shares slated for sale; it signals insider liquidity but not a governance event.

The report discloses that the securities originated from company-issued RSUs and PSUs across multiple grant dates, vesting and paid on 06/05/2025. Such disclosures are routine when insiders monetize vested compensation. The filing does not state reliance on a 10b5-1 plan or include remarks about material non-public information. On governance grounds, the filing meets disclosure norms but conveys limited substantive change to corporate control or strategy.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	THE CHARLES SCHWAB CORPORATION 3000 Schwab Way Westlake TX 76262	90000	4350000.00	301506242	10/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	06/05/2025	RSU & PSU Shares Acquired via following dates: 11/18/22 to 8/15/24	ISSUER			90000	06/05/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Dynatrace (DT) Form 144 disclose?

The notice proposes sale of 90,000 common shares via The Charles Schwab Corporation with aggregate market value $4,350,000 and an approximate sale date of 10/02/2025.

How were the Dynatrace (DT) shares acquired?

The shares were acquired as RSU & PSU awards from the issuer, with grant dates between 11/18/2022 and 8/15/2024 and an acquisition/payment date of 06/05/2025.

Does the Form 144 report any sales in the past three months for DT?

No. The filing explicitly lists "Nothing to Report" for securities sold during the past three months.

On which exchange is the proposed sale to occur?

The filing lists the NYSE as the securities exchange for the approximate sale date 10/02/2025.

How many Dynatrace shares are outstanding according to the filing?

The filing reports 301,506,242 shares outstanding.